Literature DB >> 8417160

Differences in the ligand binding properties of the short and long versions of the D2 dopamine receptor.

S W Castro1, P G Strange.   

Abstract

The short and long forms of the D2 dopamine receptor have been expressed at similar levels in fibroblast Ltk- cells, and the long form of the receptor has also been expressed in Chinese hamster ovary cells. The ligand binding properties of the two forms of receptor expressed in different systems have been compared in saturation analyses with [3H]spiperone and in competition studies with a range of antagonists. The long form of the receptor expressed in two different cell hosts exhibits essentially identical properties. However, whereas the long and short forms of the receptor show very similar affinities for several compounds representative of different chemical classes, the short form shows a two- to fivefold higher affinity for several substituted benzamide drugs. The conformation of the receptor binding site may therefore be different in the two receptor isoforms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417160     DOI: 10.1111/j.1471-4159.1993.tb05863.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

Review 1.  mRNA transcript diversity creates new opportunities for pharmacological intervention.

Authors:  Elizabeth S Barrie; Ryan M Smith; Jonathan C Sanford; Wolfgang Sadee
Journal:  Mol Pharmacol       Date:  2012-02-07       Impact factor: 4.436

2.  Mechanisms of inverse agonist action at D2 dopamine receptors.

Authors:  David J Roberts; Philip G Strange
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

3.  Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.

Authors:  Lucien Gazi; Sarah A Nickolls; Philip G Strange
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

4.  Kinetics and pharmacology of the D1- and D2-like dopamine receptors in Japanese quail brain.

Authors:  Lubica Kubíková; Pavel Výboh; Lubor Kostál
Journal:  Cell Mol Neurobiol       Date:  2009-03-28       Impact factor: 5.046

5.  Pharmacological characterization of mammalian D1 and D2 dopamine receptors expressed in Drosophila Schneider-2 cells.

Authors:  John A Schetz; Ok-Jin Kim; David R Sibley
Journal:  J Recept Signal Transduct Res       Date:  2003-02       Impact factor: 2.092

6.  Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms.

Authors:  Daniela Radl; Martina Chiacchiaretta; Robert G Lewis; Karen Brami-Cherrier; Ludovico Arcuri; Emiliana Borrelli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-18       Impact factor: 11.205

7.  Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain.

Authors:  M P Kung; S Chumpradit; D Frederick; S Garner; K D Burris; P B Molinoff; H F Kung
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

Review 8.  The role of D2-autoreceptors in regulating dopamine neuron activity and transmission.

Authors:  C P Ford
Journal:  Neuroscience       Date:  2014-01-23       Impact factor: 3.590

9.  D1/D2-dopamine receptor agonist dihydrexidine stimulates inspiratory motor output and depresses medullary expiratory neurons.

Authors:  Peter M Lalley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-11       Impact factor: 3.619

10.  Pharmacological analysis of dopamine stimulation of [35S]-GTP gamma S binding via human D2short and D2long dopamine receptors expressed in recombinant cells.

Authors:  B Gardner; D A Hall; P G Strange
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.